Pixilab
Home › Companies › SEC Form D - Biotechnology › Elysium Therapeutics, Inc.

Elysium Therapeutics, Inc.

SEC Form D private-offering issuer in Biotechnology

Elysium Therapeutics, Inc. is a business in sec form d - biotechnology based in DANVILLE, CALIFORNIA, founded in 2013.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2017Q4. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 1500000.

Its activity falls under sec form d - biotechnology; the profile below is assembled from public directory data.

The company is recorded as being based in DANVILLE, CALIFORNIA.

Its current recorded stage is Regulation D.

Recorded headcount: 1-10 employees.

It has disclosed roughly $1.5M in funding.

SectorSEC Form D - Biotechnology
HeadquartersDANVILLE, CALIFORNIA
CountryUnited States
Founded2013
Employees1-10
StageRegulation D
Total funding$1,500,000

Website: elysiumrx.com

Browse related

More SEC Form D - Biotechnology companies Companies in United States Companies founded in 2013
Contact details and direct channels are available to signed-in members.
Create a free account